US Bancorp
TSHA icon

US Bancorp’s Taysha Gene Therapies TSHA Stock Holding History

US Bancorp’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.5K Buy
1,007
+95
+10% +$442 ﹤0.01% 3604
2025
Q4 		$5.02K Hold
912
– – ﹤0.01% 3528
2025
Q3 		$2.98K Sell
912
-63
-6% -$178 ﹤0.01% 3688
2025
Q2 		$2.25K Buy
975
+44
+5% +$96 ﹤0.01% 3848
2025
Q1 		$1.29K Buy
931
+203
+28% +$340 ﹤0.01% 3946
2024
Q4 		$1.26K Sell
728
-132
-15% -$274 ﹤0.01% 3929
2024
Q3 		$1.73K Sell
860
-15,217
-95% -$33.4K ﹤0.01% 3820
2024
Q2 		$36K Sell
16,077
-1,561
-9% -$4.54K ﹤0.01% 2823
2024
Q1 		$50.6K Buy
+17,638
New +$36.8K ﹤0.01% 2685
2022
Q1 		– Sell
-524
Closed -$6K – 4201
2021
Q4 		$6K Buy
+524
New +$7.9K ﹤0.01% 3604

Other funds holding TSHA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM